Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Butovice

4 clinical trials in Butovice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Butovice at a glance
4
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Butovice

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Rheumatoid arthritis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Synact Pharma ApS
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Dr Reddy's Laboratories Limited

Psoriatic arthropathy

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Izokibep
  • Sponsor:Acelyrin Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Butovice

What the registry says about research in the country

01 Rheumatoid Arthritis Research

Innovative clinical trials focusing on rheumatoid arthritis treatment optimization through comparative studies of biosimilar medications and established therapies. Research evaluates effectiveness when combined with methotrexate for moderate to severe cases.

  • Biosimilar Treatment Evaluation
  • Combination Therapy Assessment
  • Disease Activity Monitoring

Studies aim to expand treatment options for patients with active inflammation.

02 Early-Stage Arthritis Treatment

Investigation of novel oral medications for DMARD-naïve patients with newly diagnosed rheumatoid arthritis. Research focuses on determining optimal dosing strategies and therapeutic combinations.

  • Dose Response Analysis
  • Early Intervention Strategies
  • Treatment Safety Profiles

Emphasis on developing effective treatment protocols for early-stage disease management.

03 Psoriatic Arthritis Studies

Clinical evaluation of izokibep for improving symptoms in patients with psoriatic arthritis. Research examines different dosing regimens to determine optimal therapeutic approaches.

  • Symptom Management
  • Treatment Efficacy Assessment
  • Long-term Safety Monitoring

Focus on achieving significant improvement in arthritis symptoms through targeted therapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.